All resources

June 12, 2025

Open letter

Learn more | View

March 15, 2023

Letter to the standing committee on public accounts

Learn more | View

November 28, 2022

Letter to Dr. Mélanie Bourassa Forcier, Acting chairperson, Patented Medicine Prices Review Board (PMPRB)

Learn more | View

November 18, 2022

Letter to Dr. Mélanie Bourassa Forcier, Interim Chair, Patented Medicine Prices Review Board (PMPRB)

Learn more | View

November 09, 2022

Letter to The Honourable Jean-Yves Duclos, P.C., M.P.

IMC calls for a suspension of the Patented Medicine Prices Review Board’s (PMPRB) guidelines consultation process.

Learn more | View

November 09, 2022

Letter to The Hon. Chrystia Freeland, P.C., M.P.

IMC calls for a suspension of the Patented Medicine Prices Review Board’s (PMPRB) guidelines consultation process.

*Cette lettre est disponible en anglais seulement.

Learn more | View

November 09, 2022

Letter to The Honourable Mary Ng, P.C., M.P.

IMC calls for a suspension of the Patented Medicine Prices Review Board’s (PMPRB) guidelines consultation process.

*Cette lettre est disponible en anglais seulement.

Learn more | View

November 09, 2022

Ministerial PMPRB Guideline Letter to The Hon. François-Philippe Champagne, P.C., M.P.

IMC calls for a suspension of the Patented Medicine Prices Review Board’s (PMPRB) guidelines consultation process.

Learn more | View

July 06, 2022

Developing a pan-Canadian genomics strategy: Innovative Medicines Canada response

IMC supports the creation of a Pan Canadian Genomics Strategy (PCGS) to help Canada advance its international leadership and increase capacity in genomics through commercialization and adoption.

Learn more | View

May 04, 2021

Letter to the Honourable Patty Hajdu

IMC requests that the Honourable Patty Hadju suspend the July 1, 2021 implementation of regulatory changes to the PMPRB until the COVID-19 pandemic has abated.

Learn more | View

April 30, 2021

Standing Committee on International Trade (CIIT) study of Canada’s International Trade and Investment Policy

IMC appears before the CIIT to support its study of Canada’s trade agreements and trade and investment policies regarding how they may help or hinder the production and distribution of COVID-19 vaccines domestically and abroad.

Learn more | View

April 01, 2021

IMC Open letter on Diversity, Equity and Inclusion

Learn more | View